Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DanHeart (H-HeFT / Met-HeFT): BiDil and Metformin in Chronic Heart Failure
2015-002150-12Phase 3Active
- Sponsor
- Danish Society of Cardiology
- Start
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of isosorbide dinitrate and metformin in chronic heart failure (CHF) and heart failure with reduced ejection fraction (HFrEF), sponsored by Danish Society of Cardiology. Primary endpoint: Primary composite endpoint (BiDil component). Started Jun 2017; status: active.
02
Drugs
isosorbide dinitratemetformin
03
Conditions
chronic heart failure (CHF)heart failure with reduced ejection fraction (HFrEF)
Beyond the preview
Go deeper on 2015-002150-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002150-12.